Anti-inflammatory Effect of Agaricus Blazei Murill in Inflammatory Bowel Disease (IBD)

Clinical trial NCT01496053 · COMPLETED

Trial details

NCT number: NCT01496053
Sponsor: Oslo University Hospital
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Ulcerative Colitis Crohn's Disease Inflammatory Bowel Disease

Start date: 2011-12-01
Primary completion: 2015-12-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.